Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain - Related Studies

Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

This study has been completed.

Study NCT00082316. Last updated on January 3, 2008. Information provided by NeurogesX

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Herpes Zoster
		Neuralgia
		Pain
		HIV Infections
		Peripheral Nervous System Diseases
		Diabetic Neuropathies
		Diabetes Mellitus
		Polyneuropathies

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Infection
		Nervous System Diseases

3	More general conditions related to this trial
		Diabetes Complications
		DNA Virus Infections
		Endocrine System Diseases
		Glucose Metabolism Disorders
		Herpesviridae Infections
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Metabolic Diseases
		Neurologic Manifestations
		Neuromuscular Diseases
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Signs and Symptoms
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Capsaicin Dermal Patch

5	Additional drug interventions recognized in this trial
		Capsaicin

6	More general drug interventions related to this trial
		Antipruritics
		Dermatologic Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		NeurogesX